Asensus Surgical Announces Installation of Senhance Surgical System in the Department of Gynecology at University Hospital Tübingen

RESEARCH TRIANGLE PARK, N.C., July 07, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE:ASXC ), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the installation of a Senhance® Surgical System in the Department of Gynecology at the University Hospital Tübingen. The Department of Gynecology at the University Hospital Tübingen previously initiated its Senhance Surgical program in December of 2021, as announced by the Company on January 10, 2022. The system will be initially utilized by the Department of Gynecology at the University Hospital Tübingen. Independent of the lease and utilization agreement, the Department of Gynecology at the University Hospital Tübingen has entered into a research agreement with the Company focused on collecting procedural and outcomes data for certain gynecologic procedures performed with the Senhance system. "We are very excited to be partnering with the Department of Gynecology at the University Hospital Tübingen, which is a leading institution in Germany, and Europe more broadly," said Anthony Fernando, Asensus Surgical President, and CEO. "Tübingen's gynecological surgery department is one of the most well respected in Europe, and we are proud they have decided to utilize Senhance within their state-of-the-art facilities." Asensus Surgical's technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization, and is the first platform to offer 3mm instruments (the smallest instrument available in the world on a robotic surgical platform). The Senhance Surgical System is powered by the Intelligent Surgical Unit™ (ISU™). The ISU enables machine vision-driven ... Full story available on Benzinga.com